Evidence map›Paper›PMID 40700744›Full record

ArticleJournal of proteome research2025

NMR Spectroscopy-Based Lipoprotein and Glycoprotein Biomarkers Differentiate Acute and Chronic Inflammation in Diverse Healthy and Disease Population Cohorts.

Samantha Lodge, Reika Masuda, Philipp Nitschke, John P Beilby, Jennie Hui, Michael Hunter, Edward Litton, Edward Raby, Andrew Currie, Bu B Yeap and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Dual-responsiveRSC advances · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Samantha LodgeAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.ORCID 0000-0001-9193-0462
Reika MasudaAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Philipp NitschkeAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.ORCID 0000-0002-5814-7529
John P BeilbySchool of Biomedical Sciences, University of Western Australia, Perth, WA 6009, Australia.
Jennie HuiPathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Perth, WA6009, Australia.
Michael HunterSchool of Population and Global Health, University of Western Australia, Perth, WA 6009, Australia.
Edward LittonIntensive Care Unit, Fiona Stanley Hospital, Murdoch, WA 6150, Australia.
Edward RabySchool of Medicine, University of Western Australia, Crawley, WA 6009, Australia.ORCID 0000-0003-1671-6188
Andrew CurrieSchool of Medical, Molecular and Forensic Sciences, Murdoch University, Perth, WA6150, Australia.
Bu B YeapSchool of Medicine, University of Western Australia, Crawley, WA 6009, Australia.
Oscar MilletPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, Derio 48160, Spain.ORCID 0000-0001-8748-4105
Claire CannetBruker Biospin GmbH, Rheinstetten 76287, Germany.
Hartmut SchaeferBruker Biospin GmbH, Rheinstetten 76287, Germany.
Manfred SpraulBruker Biospin GmbH, Rheinstetten 76287, Germany.
Elaine HolmesAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.ORCID 0000-0002-0556-8389
Julien WistAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.ORCID 0000-0002-3416-2572
Jeremy K NicholsonAustralian National Phenome Centre, and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.ORCID 0000-0002-8123-8349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the distribution and variation in NMR-based inflammatory markers is crucial to the evaluation of their clinical utility in disease prognosis and diagnosis. We applied high-resolution

Indexed as

GlycoproteinsInflammationLipoproteinsAcute DiseaseAdultAgedBiomarkersChronic DiseaseCohort StudiesFemaleHumansMagnetic Resonance SpectroscopyMaleMiddle AgedBiomarkersGlycoproteinsLipoproteinsacute inflammationblood plasma metabolic phenotypingcardiovascular disease riskchronic inflammationC-reactive proteindiabetesglycoproteinsinflammationNMR spectroscopySARS-CoV-2SPCSupramolecular Phospholipid Composite signals

Identifiers

PMID40700744
PMCPMC12322961

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.